CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma

Guilherme Rabinowits

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Future Oncology (London, England)
Volume	16
State	Published - Feb 1 2020

Access to Document

@article{3ab177a0b6b64398b193377c30b8f1f8,

title = "CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma",

author = "Guilherme Rabinowits",

note = "Future Oncology (London, England) (2020) 16(4):11-19",

year = "2020",

month = feb,

day = "1",

language = "American English",

volume = "16",

journal = "Future Oncology (London, England)",

}

TY - JOUR

T1 - CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma

AU - Rabinowits, Guilherme

N1 - Future Oncology (London, England) (2020) 16(4):11-19

PY - 2020/2/1

Y1 - 2020/2/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/3412

M3 - Article

VL - 16

JO - Future Oncology (London, England)

JF - Future Oncology (London, England)

ER -